Skip to main content

Rhenman & Partners Asset Management AB

Position in RLAY — Relay Therapeutics, Inc.

CIK 1599882 Stockholm, V7

Position in RLAY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$10,589,860
+$7,007,860 QoQ
Shares Held
566,000
+57.2% QoQ
Ownership
0.258%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
#57
of 258 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RLAY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rhenman & Partners Asset Management AB holds $335,352,902 across 39 Biotechnology names. RLAY ranks #14 (3.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RLAY

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,589,860 566,000
2026-03-31 $3,582,000 360,000
2025-12-31 $3,891,600 460,000
2025-09-30 $2,401,200 460,000
2025-06-30 $1,591,600 460,000
2025-03-31 $1,205,200 460,000
2024-12-31 $1,895,200 460,000
2024-09-30 $3,256,800 460,000
2024-06-30 $1,499,600 230,000
2024-03-31 $1,909,000 230,000
2023-12-31 $4,293,900 390,000
2023-09-30 $1,597,900 190,000
2023-06-30 $2,386,400 190,000
2023-03-31 $3,129,300 190,000
2022-12-31 $2,988,000 200,000